CytoDyn Inc. Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature
CytoDyn Inc. (CYDY) reported Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature of $3.54 million for the 12-month period ending 2019-05-31, per its 10-K filed 2021-07-30.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature · last filed 2021-07-30
- CytoDyn Inc. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2019-02-28 was $3.53M.
- CytoDyn Inc. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2018-11-30 was $0.00.
- CytoDyn Inc. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2018-08-31 was $0.00.
- CytoDyn Inc. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2019 was $3.54M.
- CytoDyn Inc. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2014 was $1.20M, a 80.78% decline from fiscal 2013.
- CytoDyn Inc. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2013 was $6.24M.
- CytoDyn Inc. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2010 was $38.60K.
| Period end | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 3 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 6 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 9 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 12 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 12 month as first filed |
|---|---|---|---|---|---|
| 2019-05-31 | $3.54M 10-K · filed 2021-07-30 | $3.53M 10-K · filed 2019-08-14 | |||
| 2019-02-28 | $3.53M 10-Q · filed 2019-04-09 | $3.53M derived: sum of 2 quarters · filed 2020-01-09 | $3.53M derived: sum of 3 quarters · filed 2020-01-09 | ||
| 2018-11-30 | $0.00 10-Q · filed 2020-01-09 | $0.00 derived: sum of 2 quarters · filed 2020-01-09 | |||
| 2018-08-31 | $0.00 10-Q · filed 2020-01-09 | ||||
| 2014-05-31 | $1.20M 10-K · filed 2015-07-10 | ||||
| 2013-05-31 | $6.24M 10-K · filed 2014-07-10 | ||||
| 2010-05-31 | $38.60K 10-K · filed 2013-08-29 | ||||
| 2008-05-31 | $75.00K 10-K · filed 2013-08-29 | ||||
| 2006-05-31 | $234.55K 10-K · filed 2013-08-29 |